ABBV-154 / AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABBV-154 / AbbVie
NCT05556226: Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through the Body of Adult Healthy Participants

Completed
1
40
US
ABBV-154 Dose Formulation A, ABBV-154 Dose Formulation B
AbbVie
ABBV-154
02/23
02/23

Download Options